Mesothelioma’s presentation makes it difficult to identify the cancer through imaging techniques; however, certain methods are better than others. Sometimes, the combination of two methods can provide a good idea of cancer volume and stage. In recent years, imaging is also being studied as a way to help deliver treatment directly to the cancer.
This session on imaging was held during the 2023 International Symposium on Malignant Mesothelioma in Washington, DC.
It features:
Charles Simone, MD, NY Proton Center and Memorial Sloan Kettering Cancer Center
Christopher Straus, MD, University of Chicago
This is a recording of a session at the 2023 International Symposium on Malignant Mesothelioma. This symposium is made possible by our generous sponsors: Belluck and Fox, LLP; Maune Raichle Hartley French & Mudd, LLC (MRHFM); Polaris Pharmaceuticals, Inc.; Bristol Myers Squibb; Merck; The Gori Law Firm; Ikena Oncology; Early Lucarelli Sweeney & Meisenkothen; Novacure
Find other recorded sessions and more information at www.curemeso.org/symposium
